lymphocyte gene therapy
199/13577
Phase 2 gene_therapy completed
Quick answer
lymphocyte gene therapy for Mucopolysaccharidosis II is a Phase 2 program (gene_therapy) at Ultragenyx Pharmaceutical with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ultragenyx Pharmaceutical
- Indication
- Mucopolysaccharidosis II
- Phase
- Phase 2
- Modality
- gene_therapy
- Status
- completed